-
Product Insights
Toll Like Receptor 4 – Drugs In Development, 2023
Global Markets Direct’s Toll Like Receptor 4 provides in depth analysis on Toll Like Receptor 4 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Toll Like Receptor...
-
Product Insights
Serine/Threonine Protein Kinase mTOR – Drugs In Development, 2023
Global Markets Direct’s Serine/Threonine Protein Kinase mTOR provides in depth analysis on Serine/Threonine Protein Kinase mTOR targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Serine/Threonine Protein Kinase...
-
Product Insights
Batten Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Batten Disease - Drugs In Development, 2023’, provides an overview of the Batten Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Batten Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Tay-Sachs Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Tay-Sachs Disease - Drugs In Development, 2023’, provides an overview of the Tay-Sachs Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Tay-Sachs Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Chronic Liver Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Chronic Liver Disease - Drugs In Development, 2023’, provides an overview of the Chronic Liver Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Liver Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Globoid Cell Leukodystrophy (Krabbe Disease) – Drugs In Development, 2023
Global Markets Direct’s, ‘Globoid Cell Leukodystrophy (Krabbe Disease) - Drugs In Development, 2023’, provides an overview of the Globoid Cell Leukodystrophy (Krabbe Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Globoid Cell Leukodystrophy (Krabbe Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Aortic Valve Diseases – Drugs In Development, 2023
Global Markets Direct’s, ‘Aortic Valve Diseases - Drugs In Development, 2023’, provides an overview of the Aortic Valve Diseases pipeline landscape. The report provides comprehensive information on the therapeutics under development for Aortic Valve Diseases, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Congenital Heart Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Congenital Heart Disease - Drugs In Development, 2023’, provides an overview of the Congenital Heart Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Congenital Heart Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...